Literature DB >> 2493511

Strategy and benefits of acoustic neuroma searching.

D A Moffat1, D G Hardy, D M Baguley.   

Abstract

Advances in audiological, radiological and microsurgical techniques have enabled otologists to diagnose and excise very small acoustic tumours with a low morbidity and mortality. Is this cost effective? In an attempt to answer this question, an analysis of 66 cases of surgically treated acoustic neuromas is presented. This represents part of a series of skull base procedures carried out at Addenbrooke's Hospital over the last five years. As a result of this work an investigative protocol is suggested. By studying the relative morbidity of early and late surgical intervention in these cases, and by costing the exercise, the justification for early diagnosis and treatment is presented both in financial and human terms.

Entities:  

Mesh:

Year:  1989        PMID: 2493511     DOI: 10.1017/s0022215100108023

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  6 in total

1.  Diagnosing acoustic neuroma.

Authors:  R Ramsden; R Lye; J Dutton
Journal:  BMJ       Date:  1991-05-25

2.  Should initial surveillance of vestibular schwannoma be abandoned?

Authors:  Sarah Eljamel; Musheer Hussain; M Sam Eljamel
Journal:  Skull Base       Date:  2011-01

3.  The clinical characteristics of tinnitus in patients with vestibular schwannoma.

Authors:  David M Baguley; Rachel L Humphriss; Patrick R Axon; David A Moffat
Journal:  Skull Base       Date:  2006-05

4.  Vestibular schwannoma (acoustic neuroma): the profession is not achieving its potential for early diagnosis.

Authors:  C H Tator
Journal:  CMAJ       Date:  1993-08-01       Impact factor: 8.262

5.  MRI as a single screening procedure for acoustic neuroma: a cost effective protocol.

Authors:  A K Robson; S E Leighton; P Anslow; C A Milford
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 5.344

6.  Early diagnosis and surgical management of acoustic neuroma: is it cost effective?

Authors:  D A Moffat; D G Hardy
Journal:  J R Soc Med       Date:  1989-06       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.